標(biāo)題: Titlebook: Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders; New Perspectives on Michael S. Ritsner,A. George Awad Book 2007 S [打印本頁] 作者: 游牧 時(shí)間: 2025-3-21 20:06
書目名稱Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders影響因子(影響力)
書目名稱Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders影響因子(影響力)學(xué)科排名
書目名稱Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders網(wǎng)絡(luò)公開度
書目名稱Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders被引頻次
書目名稱Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders被引頻次學(xué)科排名
書目名稱Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders年度引用
書目名稱Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders年度引用學(xué)科排名
書目名稱Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders讀者反饋
書目名稱Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders讀者反饋學(xué)科排名
作者: 草率女 時(shí)間: 2025-3-21 23:04
oratory practice.Contains methods and techiques easily transNon-clinical drug safety evaluation, the assessment of the safety profile of therapeutic agents through the conduct of laboratory studies in in vitro systems and in animals, is an essential step in the progress of new pharmaceuticals headin作者: MONY 時(shí)間: 2025-3-22 00:27
Michael S. Ritsneroratory practice.Contains methods and techiques easily transNon-clinical drug safety evaluation, the assessment of the safety profile of therapeutic agents through the conduct of laboratory studies in in vitro systems and in animals, is an essential step in the progress of new pharmaceuticals headin作者: epinephrine 時(shí)間: 2025-3-22 04:39 作者: bronchodilator 時(shí)間: 2025-3-22 09:59 作者: 終端 時(shí)間: 2025-3-22 16:10
Talma Hendler,Roee Admon,David Papo in biology. Developed over 50 years ago, and with different principles to detect and map compounds on a sample surface, MSI supports modern biology questions by detecting biological compounds within tissue sections. MALDI (matrix-assisted laser desorption/ionization) imaging trend analysis in this 作者: anachronistic 時(shí)間: 2025-3-22 18:14 作者: Pamphlet 時(shí)間: 2025-3-22 21:29
Graeme Hawthorne in biology. Developed over 50 years ago, and with different principles to detect and map compounds on a sample surface, MSI supports modern biology questions by detecting biological compounds within tissue sections. MALDI (matrix-assisted laser desorption/ionization) imaging trend analysis in this 作者: SENT 時(shí)間: 2025-3-23 05:06 作者: Offstage 時(shí)間: 2025-3-23 08:56
Ralf Pukrop,Andreas Bechdolfdogenous . gene of treated rats by using flow cytometry to measure changes in cell surface markers of peripheral blood cells. Here we present a methodology for demonstrating that phenotypically mutant rat T-cells identified by flow cytometry contain mutations in the . gene, an important step for val作者: painkillers 時(shí)間: 2025-3-23 10:44 作者: 六邊形 時(shí)間: 2025-3-23 14:36 作者: 刺耳 時(shí)間: 2025-3-23 19:12 作者: Mediocre 時(shí)間: 2025-3-23 23:00 作者: 北京人起源 時(shí)間: 2025-3-24 03:29 作者: declamation 時(shí)間: 2025-3-24 09:32 作者: FELON 時(shí)間: 2025-3-24 10:57 作者: bacteria 時(shí)間: 2025-3-24 15:58
Julio Bobes,M.-P. García-Portilla,Maria-Teresa Bascarán,Pilar-Alejandra Sáiz,Maria-Teresa Bobes-Bascics have replaced other drugs as the agents of choice in the treatment of anxiety and insomnia.. During this 25-year period a total of 13 benzodiazepine derivatives have been marketed in the United States. For this to occur a vast literature has accumulated reporting the preclinical and clinical tes作者: Orchiectomy 時(shí)間: 2025-3-24 21:24 作者: gnarled 時(shí)間: 2025-3-25 02:18
A. George Awad,Lakshmi N.P. Voruganticovered by phenotypic-based screening methods. However, identifying molecular targets for these bioactive compounds is a very laborious process. With the development and advancements in new methodologies and techniques for identification and biological analysis, various target identification methods作者: 擺動(dòng) 時(shí)間: 2025-3-25 06:39
ve subjects, lists of the necessary materials, step-by-step, readily reproducible protocols, and tips on troubleshooting and avoiding known pitfalls.Comprehensive and authoritative, Drug Safety Evaluation: Methods and Protocols serves as an ideal guide to this field, helpful to pharmaceutical scient作者: 離開可分裂 時(shí)間: 2025-3-25 10:23
Lakshmi N.P. Voruganti,A. George Awadve subjects, lists of the necessary materials, step-by-step, readily reproducible protocols, and tips on troubleshooting and avoiding known pitfalls.Comprehensive and authoritative, Drug Safety Evaluation: Methods and Protocols serves as an ideal guide to this field, helpful to pharmaceutical scient作者: DEFER 時(shí)間: 2025-3-25 15:12 作者: 關(guān)節(jié)炎 時(shí)間: 2025-3-25 17:30
Talma Hendler,Roee Admon,David Papovelopment phases. MSI allows to potentially address important questions in drug development such as “What is the localization of the drug and its metabolites in the tissues?”, “What is the pharmacological effect of the drug in this particular region of interest?”, or “Is the drug and its metabolites作者: CT-angiography 時(shí)間: 2025-3-25 21:55
Monika Bullinger,Silke Schmidt,Dieter Naberbination a detailed review of the nonclinical data available may suffice, particularly when the components have a history of coadministration at about the same dose and ratio as that of the proposed combination. For a marketed drug/NME combination, in addition to a review of the data for the markete作者: 可觸知 時(shí)間: 2025-3-26 04:12
Graeme Hawthornevelopment phases. MSI allows to potentially address important questions in drug development such as “What is the localization of the drug and its metabolites in the tissues?”, “What is the pharmacological effect of the drug in this particular region of interest?”, or “Is the drug and its metabolites作者: forestry 時(shí)間: 2025-3-26 05:53
Michael S. Ritsnervelopment phases. MSI allows to potentially address important questions in drug development such as “What is the localization of the drug and its metabolites in the tissues?”, “What is the pharmacological effect of the drug in this particular region of interest?”, or “Is the drug and its metabolites作者: 整潔漂亮 時(shí)間: 2025-3-26 11:54 作者: Silent-Ischemia 時(shí)間: 2025-3-26 15:08 作者: CEDE 時(shí)間: 2025-3-26 19:04
Andreas Bechdolf,Verena Veith,Ralf Pukrop,Joachim Klosterk?tter When treatment fails, either ab initio or subsequent to an initial response, the risk-benefit relationship of drugs inevitably alters. For this reason the main factors responsible for treatment failure have been considered, with special attention to the possible contribution of or implications for 作者: CHOP 時(shí)間: 2025-3-26 21:26 作者: ALIEN 時(shí)間: 2025-3-27 01:31
Paul H. Lysaker,Shira Louriaillnesses. When treatment fails, either ab initio or subsequent to an initial response, the risk-benefit relationship of drugs inevitably alters. For this reason the main factors responsible for treatment failure have been considered, with special attention to the possible contribution of or implications for 978-3-540-12811-3978-1-4471-1351-5作者: Abduct 時(shí)間: 2025-3-27 06:54
Marcelo T. Berlim,Marcelo P.A. FleckDC) and Food and Drug Administration (FDA) monitors post-licensure vaccine efficacy and safety using various methods and techniques. Advanced kinetic models are used to calculate the degradation kinetics rate of biological products such as protein and virus-based vaccines and also an emulsion-based 作者: Mnemonics 時(shí)間: 2025-3-27 10:06 作者: Enliven 時(shí)間: 2025-3-27 15:40 作者: ungainly 時(shí)間: 2025-3-27 20:37 作者: airborne 時(shí)間: 2025-3-27 23:55 作者: APO 時(shí)間: 2025-3-28 04:34
A. George Awad,Lakshmi N.P. Vorugantiantages as well as disadvantages. The efficient execution of every scientific process involves significant infrastructure set up and expertise in multiple disciplines (chemistry, proteomics, genomics, and bioinformatics). The collaborative work scheme comprising integrated knowledge of all of these 作者: Verify 時(shí)間: 2025-3-28 06:48 作者: iodides 時(shí)間: 2025-3-28 11:50
Neuroendocrine functions, mood and quality of lifeelopment of novel neuropharmacological intervention strategies. Future directions for research are described..All data derived from studies focusing on central neuropeptidergic circuits and peripheral hormone systems add to the understanding of the pathophysiology of mood disorders and indicate the 作者: overhaul 時(shí)間: 2025-3-28 15:08
In the mind of the Beholder Neuronal mediators for the effect of emotional experience on~quality of ntiation. In other words, a resilient affective style may be associated with weak reaction and fast recovery from negative stressful events, while affective vulnerability may result in excessive response to and long standing distress from the same stressful event. Thus, the ability to assign appropr作者: 礦石 時(shí)間: 2025-3-28 20:16 作者: 整頓 時(shí)間: 2025-3-29 02:02
Integrative bottom-up approach to HRQOL measurementg vs. depressed mood and six specific QOL dimensions. This basic structure represents a core module which holds for nonclinical and clinical samples, and which can be completed by specific modules for particular subpopulations (e.g. persons with family, partnership, profession). Reliability, validit作者: 懶鬼才會(huì)衰弱 時(shí)間: 2025-3-29 03:10
Health Related Quality of Life in Subjects at Risk for a First Episode Of Psychosisjoining school or work and higher positive prodromal symptom scores. In FE HRQL scores were negatively correlated with age and depression. The major finding from the study is that HRQL in subjects at risk for a first episode of psychosis is substantially reduced when compared with HC. Thus, HRQL may作者: Ornithologist 時(shí)間: 2025-3-29 10:09 作者: 滋養(yǎng) 時(shí)間: 2025-3-29 12:30 作者: deriver 時(shí)間: 2025-3-29 18:33 作者: IVORY 時(shí)間: 2025-3-29 20:07 作者: cinder 時(shí)間: 2025-3-30 01:20
Quality of Life Impairment in Anxiety Disordersepidemiologic studies and empirical research investigations on QOL and functional impairment in generalized anxiety disorder, panic disorder, posttraumatic stress disorder, and generalized social phobia. We will discuss the findings, address strengths and weakness of the current research, and sugges作者: intrigue 時(shí)間: 2025-3-30 07:21
